31 – 40 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD : FLAME-based modelling in a Swedish population
- Contribution to journal › Article
-
Mark
Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF
- Contribution to journal › Letter
-
Mark
IL-18 associated with lung lymphoid aggregates drives IFNγ production in severe COPD
- Contribution to journal › Article
-
Mark
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease
- Contribution to journal › Article
- 2016
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
- Contribution to journal › Article
-
Mark
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
- Contribution to journal › Article
- 2015
-
Mark
Small airway epithelial-C/EBPβ is increased in patients with advanced COPD.
- Contribution to journal › Article
-
Mark
Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study
- Contribution to journal › Article
- 2014
-
Mark
Controlled and uncontrolled asthma display distinct alveolar tissue matrix compositions
- Contribution to journal › Article
-
Mark
lObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study
- Contribution to journal › Article
